BioRestorative Therapies, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

BioRestorative Therapies, Inc. reported Cash And Cash Equivalents At Carrying Value of $1.51 million for the year ending 2025.

  • BioRestorative Therapies, Inc. showed an increase of +175.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from BioRestorative Therapies, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
  • XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2021 to 2025), BioRestorative Therapies, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 92.8%.
  • Historical annual values: Fiscal year 2025: $1.51 million | Fiscal year 2024: $547.9 thousand | Fiscal year 2023: $884.4 thousand | Fiscal year 2022: $1.71 million | Fiscal year 2021: $21.03 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: